WO2003008536A2

WO2003008536A2 - A system for intracellular process monitoring and in vivo drug screening

Info

Publication number: WO2003008536A2
Application number: PCT/KR2002/001345
Authority: WO
Inventors: Inhwan Hwang; Dae Heon Kim; Yong Jik Lee; Jing Bo Jin
Original assignee: Ahram Biosystems Inc.
Priority date: 2001-07-16
Filing date: 2002-07-16
Publication date: 2003-01-30
Also published as: WO2003010507A2; KR20030007221A; KR100919637B1; AU2002339228A1; WO2003010507A3; KR20040015804A

Abstract

This invention relates to a method for selectively detecting specific characteristics related to intracellular trafficking and subcellular localization of a selected protein by observing a fluorescence image, and a method for selectively screening chemicals that affect such specific characteristics of the protein in a cell.

Description

A SYSTEM FOR INTRACELLULAR PROCESS MONITORING AND IN VIVO

DRUG SCREENING

Technical Field

The present invention relates to the technology in cell molecular biology. More particularly, it relates to methods that make it possible to selectively observe intracellular trafficking of a selected protein and also to selectively screen new drugs that affect the expression or the intracellular trafficking of a selected protein in vivo. Especially, the present invention relates to a cell-based detection system that uses cells transformed to express a reporter protein labeled with a fluorescent protein.

Background Art

The recent rapid development in biotechnology makes it possible to collect primary information on the whole genomic sequence and the expression pattern of the total cellular proteins of an organism. Genomics and Proteomics researches become new leading trends to discover valuable genes and proteins from the vast amount of the primary information and also to elucidate and use the correlations among such bio-information. In order to extract and use valuable information from such vast primary information, it is necessary to develop technologies that can selectively and quickly sort and detect the detailed processes of the complex biological phenomena, as realized in the present invention. Developing such technologies is one of the leading trends as found in various recent arts pertaining to the present invention. The most important usage of the large amount of the useful information obtained from Genomics and Proteomics is for developing new drugs. Establishment of efficient and selective drug screening systems based on such useful bio-information is expected to play a major role in evolution of the biotechnology. Therefore, researches for developing new drug screening systems have been actively carried out recently.

Development of a new drug screening system depends basically on (1) discovery and establishment of a specific target related to a disease or a biological regulation process, and (2) development and optimization of an assay method to determine the effects of drug candidates on a specific target. In order to develop efficient drug screening systems, therefore, selective detection techniques must be developed first. Such detection techniques can be used to identify detailed causes of biological phenomena from the vast amount of the genetic and proteomic information, or to detect specific intracellular or intercellular processes related to such causes. These selective detection techniques provide fundamental basis not only for identifying specific targets for drug screening, i.e., biological factors causing specific phenomena, but also for establishing systematic assay methods that allow more selective drug screening. The assay method to evaluate the effects of drug candidates on a specific target can be categorized into three classes. The first is a protein- or a molecule-based method in which the effect of the drug candidate on the activity of an enzyme or a receptor critical in the induction mechanism of a disease is directly observed to screen the drug candidates. The second is an organism-based method in which the effect of the drug candidate on the morphological or biochemical characteristics of an organism is observed to screen the drug candidates. The last is a cell-based method in which the effect of the drug candidate on the morphology of the cell or subcellular organelles, and expression, trafficking, and metabolism of proteins in the cell is observed to screen the drug candidates. The protein-based method has the advantage that the assay can be performed for a specific target protein. However, because the assay is conducted in vitro, it is not possible to examine various complex cellular factors. Therefore, it requires many additional time-consuming experiments before examining the drug candidate to a living organism. On the other hand, the organism- or cell- based method can detect the composite changes of the organism or the cell induced by the drug candidates. But it also requires additional time-consuming experiments to confirm that the drug candidate specifically affects the target gene or protein.

To overcome such problems of the prior drug screening methods, new technologies are recently under development using genetic transformation techniques. Genetic functions of a specific gene or biological functions of a protein expressed from the specific gene can be elucidated by examining the phenotype of the transformed organism or cell. Drug candidates can be more selectively screened by examining their effects on the specific phenotype of the transformed organism or cell.

Previously, the radioisotope labeling method has been frequently used to selectively observe a specific phenomenon in a cell or an organism. Recently, fluorescent proteins such as green fluorescent protein (GFP), red fluorescent protein (REF) (Moris et al., 1974), and their derivatives (Evans, W098/21355) that can be expressed in the cell have been developed, and various researches have been reported using expression of these fluorescent proteins. Examples of using the fluorescent proteins include observation of the gene expression and subcellular protein localization (Chalfie and Prasher, US5491084), visualization of the subcellular organelles (Kost et al., 1998), visualization of the protein trafficking in the secretory pathway (Kaether and Gerdes, 1995), and visualization of the protein expression pattern in a plant cell (Hu and Cheng, 1995) and in Drosophila embryo (Davis and Viestra, 1998). The fluorescent proteins have been also used to develop new drug screening methods. Examples include a method using mutated organisms transformed to express a modified GFP (Ward and Chalfie, W095/21191), a method using a cell transformed to express a fusion protein comprising a fluorescent protein and a transcription factor related to the activity of a cell surface receptor which regulates signal transduction (Harpold et al., US5401629), and a method using a cell transformed to express a fusion protein comprising a fluorescent protein and the active site of the protein kinase (Thastrup et al., WO96/23898).

Among these studies that utilize the expression of the fluorescent proteins, several examples showed that intracellular processes related to specific proteins can be selectively observed among the complex cellular processes by visualizing the expression and trafficking of a selected protein (Ward and Chalfie, WO95/21191; Kost et al, 1998; Gilooly et al., 2000; Pih et al., 2000). These results provide means for selectively screening drug candidates that affect a specific intracellular process. Various researches have reported signal proteins that have trafficking signals targeting to specific subcellular organelles. For example, the chlorophyll-binding proteins are transported to chloroplast, the nuclear localization signal domain (NLS domain) of SN40 is targeted to the nucleus (Goldfarb et al., 1986), the peroxisome targeting motif SKL is targeted to peroxisome (Davis and Viestra, 1998), and Fl- H⁺-ATPase is transported to mitochondria (Νiwa et al., 1999). As in these examples, most of proteins in the cell are transported to specific subcellular organelles related to their functions. Therefore, it is possible to visualize and observe intracellular trafficking of a specific signal protein (Harpold et al., US5401629; Kost et al., 1998) and also to selectively observe and examine the effect of a drug candidate on a specific intracellular process (Morinaga et al., 1999) by expressing a fusion protein comprising a fluorescent protein and a specific signal protein having a trafficking signal targeting to a subcellular organelle. Phospholipid-specific intracellular processes can also be observed by expressing phospholipid-binding proteins linked to a fluorescent protein. For example, PLC-Delta PH (Stauffer et al., 1998), AtPH, and FAPP1 (Dowler et al., 2000) domains are known to bind specifically to PI(3,4)P2, PI(3)P, and PI(4)P, respectively. A fusion protein having the PH domain and GFP was shown to be translocated to the plasma membrane when expressed in a cell (Kost et al., 1998). As described above, it is possible to elucidate detailed nature of the intracellular processes by observing intracellular trafficking and localization of a specific protein labeled with a fluorescent protein. Selective drug screening methods can also be developed based on such detection scheme. However, intracellular processes are very complicated because several thousands or several tens of thousands proteins are involved in these processes. To develop a realistic method that can be used to detect each of the complicated intracellular processes selectively and systematically, many different fusion proteins having fluorescent protein labels have to be constructed to enable selective detection of diverse intracellular processes, and the specific intracellular characteristics of these fusion proteins need to be elucidated. Furthermore, it is necessary to develop a method for preparing transformed cells that can efficiently express the fusion proteins and also a systematic method for obtaining and analyzing the fluorescence image resulted from the fusion protein.

Disclosure of Invention

In compliance with the above requirements, it is an objective of the present invention to provide a method for selectively detecting the diverse and complex intracellular processes and a detailed method for selectively screening chemicals that affect a specific intracellular process based on the above detection method. To accomplish this object, the present invention provides:

(1) an efficient method for preparing a transformed cell to express a reporter protein comprising a signal protein having a trafficking signal targeting to a specific intracellular organelle and a fluorescent protein linked thereto,

(2) detailed methods for preparing various recombinant genes, each comprising a gene encoding a signal protein and a gene encoding a fluorescent protein linked thereto, and (3) methods for constructing recombinant plasmids that can be used to efficiently express the reporter proteins in a cell.

The present invention also provides a systematic method for transforming a cell with the recombinant plasmid and expressing efficiently the reporter protein in the transformed cell. Furthermore, the present invention provides a detailed method for monitoring details of the intracellular distribution of the reporter protein in a living cell by observing the fluorescence image either continuously or step by step during the expression and trafficking processes. In addition to providing the efficient systematic method for measuring the spatial distribution specific to the expression and trafficking processes of a selected protein in the transformed cell, it is another objective of the present invention to provide a method for selectively screening drug candidates that affect a specific intracellular process in the transformed cell. In order to expand and systemize the usages of the selective detection method for the intracellular processes and the drug screening method based on this detection method, the present invention provides recombinant genes for diverse signal proteins that direct targeting to specific intracellular organelles such as nucleus, mitochondria, chloroplast, peroxisome, plasma membrane, endoplasmic reticulum, Golgi apparatus, storage vacuole, lytic vacuole, prevacuolar compartment, etc. In addition, the present invention aims to provide an optimized overall procedure from the construction of the recombinant plasmids to the preparation of the transformed cells.

In the present invention, we establish a method for selectively detecting specific characteristics related to intracellular trafficking and localization of a selected protein and a method for selectively screening chemicals that affect such specific cellular characteristics of the selected protein.

We expand the applicability of the present invention by providing the detailed methods for preparing the transformed cells that can express diverse reporter proteins targeting to various subcellular organelles. Therefore, a fundamental basis is provided for using more systematically and more thoroughly the selective detection method for the intracellular processes and the selective drug screening method based on this detection method.

Also, we established a method for determining the detailed effects of chemicals by examining the effects of several known chemicals on the intracellular processes. In further detail, the present invention provides (1) the method for selectively screening chemicals that affect the intracellular trafficking and localization of a selected protein, (2) the method for screening chemicals that inhibit or enhance the transcription or translation process by monitoring the effects of the chemicals on the expression of the reporter protein, and (3) the method for screening cytotoxic chemicals by observing the effect of chemicals that cause deformation, damage, or disruption of subcellular cellular organelles.

Brief Description of Drawings

Figure 1 shows schematic diagrams of the reporter proteins targeting to the subcellular organelles enclosed by membrane, which are classified as Group I proteins in the present invention.

Figure 2 shows fluorescence images showing the expression of the Group I reporter proteins in the cell, wherein (a) shows that AtOEP7:GFP is localized to the envelope of chloroplast, wherein the red fluorescent signal is the auto-fluorescence signal of chloroplast and the yellow fluorescence signal is an merged image of the auto-fluorescence signal of chloroplast and the green fluorescence signal of the reporter protein;

(b) is a photograph where the red auto-fluorescence of chloroplast in (a) is eliminated by using a filter;

(c) shows that Rubisco small subunit (RbcS) is localized in the stroma of chloroplast;

(d) shows that Cab:GFP emits in the chloroplast;

(e) shows that Rubisco Activase (RA) linked to GFP is localized in the chloroplast;

(f) shows that FI- H⁺-ATPase linked to GFP is localized in the mitochondria; (g) shows that peroxisome targeting signal (SKL) linked to GFP is localized in the peroxisome envelope; and

(h) shows that nuclear localization signal (NLS) linked to GFP is localized in the nucleus.

Figure 3 shows a photograph of a Western blot analysis of the expressed AtOEP7:GFP, wherein T, S, and M indicate the total protein extract, the soluble fraction, and the membrane fraction, respectively.

Figure 4 shows schematic diagrams of the reporter proteins targeting to the subcellular organelles by endosomal trafficking, which are classified as Group II proteins in the present invention. Figure 5 shows fluorescence images showing the expression of the Group II reporter proteins in the cell, wherein

(a) shows that H⁺-ATPase:GFP is localized in the plasma membrane;

(b) shows the fluorescence image of sialtransferase (ST) translocated in the Golgi apparatus, wherein the red fluorescence signal is the auto-fluorescence signal of chloroplast; (c) shows that the reporter protein BiP:RFP is localized in the lumen of the endoplasmic reticulum;

(d) shows that 500:GFP:KKXX is localized in the membrane of the endoplasmic reticulum;

(e) shows that 526:GFP is localized in the storage vacuole; (f) shows that Chi-n:RFP:Chi-c is localized in the storage vacuole;

(g) shows that Chi-n:GFP, in which the carboxyl terminus of the signal protein, chitinase, is not present, fails to translocate in the storage vacuole but appears as speckles in the endoplasmic reticulum; and

(h) shows that SPO:GFP is distributed evenly in the lytic vacuole. Figure 6 shows schematic diagrams of the reporter proteins binding specifically to phospholipids, which are classified as the Group III proteins in the present invention.

Figure 7 shows fluorescent images showing the expression of the Group III reporter proteins, wherein

(a) shows that the reporter protein GFP:EBD emits fluorescence at the outer membrane of vacuole, indicating that phosphatidylinositol 3 -phosphate (PI(3)P) is present on the outer membrane of vacuole;

(b) shows that GFP:FAPP1 emits fluorescence in the plasma membrane indicating that phosphatidylinositol 4-phosphate (PI(4)P) is present in the plasma membrane; and

(c) shows that GFP:PH emits fluorescence in the plasma membrane, indicating that phosphatidylinositol 4,5-diphosphate (PI(4,5)P2) is present in the plasma membrane.

Figure 8 shows photographs representing the inhibitory effect of wortmannin on the intracellular trafficking of a Group I reporter protein RbcS: GFP. Wortmannin is known to be an inhibitor of PI(3)P and PI(4)R

(a) shows that RbcS:GFP is targeted correctly to the chloroplast in the control protoplast, as expected. (b) and (c) show that in the presence of wortmannin, the green fluorescence signal is not located in the chloroplast but appears as speckles or aggregates.

Figure 9 shows photographs representing the effect of a chemical on the intracellular trafficking of a Group II reporter protein, wherein (a) and (b) show that the green fluorescence signal of 500:GFP:KKXX is observed as numerous networks in the control protoplast; and

(c) and (d) show that in the presence of BafAl, the green fluorescent signal is observed as ring patterns in the plasma and vacuolar membranes.

Figure 10 shows photographs showing the change induced by a specific inhibitor upon co-expression of two reporter proteins, wherein

(a) and (b) show the green and red fluorescent signals in the control protoplast, respectively;

(d) shows that treatment with brefeldin A does not affect BiP;

(e) shows that treatment with brefeldin A disrupts the Golgi apparatus and thus ST is transported to the endoplasmic reticulum instead of the Golgi apparatus; and

(c) and (f) show that the control protoplast and the brefeldin A-treated protoplast represent distinctive difference in their fluorescence images.

Figure 11 shows photographs that visualize the effects of brefeldin A disrupting the subcellular organelles, wherein (a) shows that BiP:RFP is distributed along the structure of the endoplasmic reticulum in the control protoplast;

(c) visualizes that the disrupted structure of the endoplasmic reticulum in the presence of brefeldin A; and

(b) and (d) show the protoplasts in (a) and (c) observed under bright field. Figure 12 shows photographs representing the inhibitory effect of chemicals on Group III reporter proteins, wherein

(a) shows that the green fluorescence signal in the control protoplast is located on the vacuolar membrane along the distribution of PI(3)P which binds to EBD, but in the presence of wortmannin or LY294002, the green fluorescence signal is distributed throughout the cytosol; and

(b) shows that the distribution of the fluorescence signal is not affected by the above chemicals when the same experiments were performed with GFP:EBDC1358S, in which the amino acid residue 1358 of EBD was mutated.

Figure 13 shows photographs showing the variation in the intensity of the fluorescent signal induced by an expression inhibitor, wherein

(a) shows that the intensity of the green fluorescence is decreased in the cycloheximide-treated protoplast compared to that in the control protoplast of (b); and

(c) and (d) show the auto-fluorescence signal of the chloroplast presented for relative comparison of the cell growth and the metabolism conditions.

Best Mode for Carrying Out the Invention

To accomplish the objectives, in the first aspect, the present invention provides a method for detecting specific characteristics related to trafficking and localization of a selected protein in a cell, which method comprises:

(a) preparing a recombinant gene comprising a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto;

(b) preparing a recombinant plasmid comprising the recombinant gene with a promoter and a terminator operably linked thereto so that the recombinant gene can be expressed in the cell;

(c) transforming the cell with at least one recombinant plasmid prepared in step (b);

(d) expressing the reporter protein comprising the signal protein and the fluorescent protein in the transformed cell; and (e) detecting the cellular distribution of the reporter protein by monitoring the fluorescence image of the transformed cell during the expression or trafficking, or thereafter.

In the second aspect, the present invention provides a method for screening chemicals that affect specific characteristics related to trafficking and localization of a selected protein in a cell, which method comprises:

(d) expressing the reporter protein comprising the signal protein and the fluorescent protein in the transformed cell, while treating the transformed cell with a chemical before, after, or at the same time as the expression;

(e) detecting the cellular distribution of the reporter protein by monitoring the fluorescence image of the transformed cell treated with the chemical during the expression or trafficking, or thereafter; and

(!) determining the effect of the chemical by comparing the fluorescence image obtained in step (e) with that of a control transformed cell which is not treated with the chemical. In the third aspect, the present invention provides recombinant genes encoding the reporter proteins that are used in the above methods to visualize the trafficking of the reporter proteins and their distributions in subcellular organelles. The recombinant gene comprises a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto.

Details of the compositions of the present invention are described below. In the present invention, the signal protein is selected from the proteins that have trafficking signals targeting to nucleus, mitochondria, chloroplast, peroxisome, plasma membrane, endoplasmic reticulum, Golgi apparatus, storage vacuole, lytic vacuole, and prevacuolar compartment, and also those proteins targeting to 3 classes of phospolipids. Examples of the signal proteins include NLS (nuclear localization sequence), AtOEP7, Cab (chlorophyll a/b binding protein), SKL (peroxisome targeting motif), RbcS (rubisco small subunit), RA (rubisco activase), Fl- H⁺-ATPase, H⁺-ATPase, BiP (chaperone binding protein), ST (Sialyltransf erase). Chi (chitinase), recombinant clone 526, clone 491, clone 500, AtVTIla, SPO (sporamin), EBD, AtPH, FAPP, PH, etc. The present invention provides methods for preparing transformed cells that can express reporter proteins, each comprising one of the signal proteins described above and a fluorescent protein label linked thereto. The present invention also provides a systematic method for selectively detecting the intracellular processes using the transformed cells and a systematic method for selectively screening drug candidates based on this detection method.

More particularly, the methods of the present invention include a step of selecting a specific protein that has a property of translocating to a specific subcellular location, a step of synthesizing the whole gene of the selected signal protein or a portion thereof encoding the trafficking signal of the selected protein, a step of synthesizing a gene encoding a fluorescent protein that can be linked to the signal protein to fluorescently visualize the subcellular localization, and a step of constructing a recombinant gene comprising a gene encoding the signal protein and a gene encoding the fluorescent protein linked thereto. The function of the signal protein can change depending on the way that the fluorescent protein is linked to the signal protein. The present invention therefore provides compositions of the reporter proteins whose signal proteins can correctly direct the trafficking, and also construction methods thereof.

The present invention also provides a procedure for constructing recombinant plasmids that can be used to express the recombinant genes in a cell. The recombinant plasmid can be constructed by ligating a recombinant gene into a vector containing a promoter, a terminator, and other necessary factors. As well known to the persons having ordinary skills in the art to which the present invention pertains, methods for transforming a cell by introducing the recombinant plasmid include, but are not limited to, chemical- mediated methods using PEG (polyethylene glycole), potassium phosphate, or DEAE- dextran, cationic lipid-mediated lipofection, microinjection, electroporation, and electrofusion. In the transformation, one type of the recombinant plasmid could be introduced, or else two or more types of the recombinant plasmids can be introduced to express two or more reporter proteins simultaneously. The conditions need to be optimized to efficiently express the reporter protein comprising the signal protein and the fluorescent protein in the transformed cell. The persons skilled in the art can select appropriate conditions depending on the signal protein and the fluorescent protein used. Detailed structures of the recombinant plasmids are explained in the examples of the present invention to present the amino acid sequences of the reporter proteins or corresponding nucleic acid sequences. In constructing the reporter proteins according to the present invention, the signal proteins were classified into three classes based on the protein trafficking mechanisms, in order to show that the methods of the present invention for constructing the reporter proteins can be commonly used for various mechanisms of protein trafficking to different subcellular organelles. Signal proteins targeting to nucleus, chloroplast, mitochondria, etc., correspond to the case that a specific portion of the signal protein directly acts as a recognition signal to direct the intracellular trafficking. These signal proteins are classified as Group Ϊ for convenience in the specification of the present invention (see Figure 1). Signal proteins targeting to endoplasmic reticulum, Golgi apparatus, lytic vacuole, storage vacuole, plasma membrane, etc., correspond to the case of the endosomal trafficking in which a specific portion of the signal protein acts as a signal to be captured by endoplasmic reticulum so that the signal protein is translocated as enclosed in endoplasmic reticulum. These signal proteins are classified as Group II for convenience in the specification of the present invention (see Figure 4). In the present invention, detailed methods are provided for visualizing the trafficking processes and the cellular distributions of these classes of the signal proteins. In addition, signal proteins related to intracellular signal transduction via specific binding to phospolipids are selected in the present invention, and methods are provided for observing the subcellular organelles that contain specific phospholipid. These signal proteins are classified as Group III for convenience in the specifications of this invention (see Figure 6).

Using the trafficking properties of these signal proteins, details of the subcellular localization of the signal proteins can be specifically visualized, for example, on the membrane, or inside or outside of an organelle. The present invention also provides a method for visualizing the localization of two or more proteins simultaneously by using two or more fluorescent proteins with different colors.

In the embodiments of the present invention, green fluorescent protein (GFP, Davis and Niestra, 1998) and red fluorescent protein (RFP) are used for constructing the reporter proteins to visualize their cellular localization. However, the person having ordinary skill in the art to which the present invention pertains can fully understand that the reporter proteins of the present invention can be constructed by using fluorescent proteins other than GFP and RFP. The expression and trafficking processes of the reporter protein can be visualized in details for each stage of the processes by continuously monitoring the images of the fluorescence emitted by the reporter protein expressed in the transformed cell, using a fluorescence microscope at a specific wavelength.

As it becomes possible to detect the expression and trafficking processes of a specific protein and its cellular distribution, a selective drug screening system for identifying chemicals inhibiting or enhancing the intracellular trafficking of the selected protein is established using this detection method. More particularly, it is demonstrated that chemicals affecting the intracellular trafficking can be identified by treating the transformed cell with a chemical before, after, or at the same time as the expression of the reporter protein, and then identifying the effect of the chemical by comparing the cellular distribution of the reporter protein in the transformed cell treated with the chemical with that in the control transformed cell which is not treated with the chemical.

The same method can be used to screen chemicals inhibiting or enhancing the transcription or the translation of proteins because the level of the protein expression can be examined from decrease or increase in the intensity of the fluorescence signal from the reporter protein. This is also demonstrated in the examples of the present invention.

Morphological changes induced by a chemical, such as modification, damage, or destruction of the subcellular organelles can be detected by observing the distribution or pattern of the fluorescence signal from the reporter protein. Therefore, it is also possible to screen cytotoxic chemicals that cause alteration of the subcellular organelles. This is also demonstrated in the examples of the present invention.

In order to show that the selective drug screening system provided by the present invention can be used practically, known inhibitors such as bafilomycin Al, wortmannin, and brefeldin A are examined to confirm that inhibition of the intracellular trafficking and expression processes and also cytotoxicity causing morphological changes of the subcellular organelles can be detected practically. This is described in detail in the examples of the present invention. As described in the examples, the signal proteins included in Group I, II, and III are examined to check the difference arising from the protein trafficking mechanisms.

Compositions and usages of the present invention are described in detail in the embodiments with the attached drawings. The embodiments are to explain, but not limit, the present invention. The person having ordinary skill in the art to which this invention pertains can easily recognize other objects and advantages of the present invention from the attached drawings, the detailed description, and the claims of the present invention.

Example 1. Construction of recombinant plasmids for expression of Group I proteins targeting to the organelles across the membrane.

The coding region for the transit peptide of Fl-H⁺-ATPase (access number D88374) was amplified by polymerase chain reaction (PCR) from a λZAPII cDNA library using two specific primers (5'-CTTTAATCAATGGCAATG (SEQ ID NO: 1) and 5'- CCATGGCCTGAACTGCTCTAAGCTT (SEQ ID NO: 2)) and ligated in-frame to the 5' end of the coding region of the green fluorescent protein to generate a recombinant gene for Fl- H⁺-ATPase:RFP (Niwa et al, 1999). The recombinant gene was subcloned into pUC under the control of the 35S promoter to construct a recombinant plasmid for ATPase:RFP. The same method was used for construction of other recombinant plasmids. To express the reporter protein of the ribulose bisphosphate carboxylase (Rubisco) complex, the coding region for the transit peptide of the small subunit of the Rubisco complex was PCR amplified from a λZAPII cDNA library using two specific primers (5'- CCTCAGTCACACAAAGAG (SEQ ID NO: 3) and 5'-

ACTCGAGGGAATCGGTAAGGTCAG (SEQ ID NO: 4)). The resulting PCR product was subcloned into pBluescript and subsequently ligated in-frame to the 5' end of the coding regions of GFP and RFP to construct recombinant plasmids for RbcS:GFP and RbcS:RFP, respectively.

The coding region of the chloroplast a/b binding protein was PCR amplified from a λZAPII cDNA library using two specific primers (5'-TAGAGAGAAACGATGGCG (SEQ ID NO: 5) and 5'-GGATCCCGTTTGGGAGTGGAACTCC (SEQ ID NO: 6)) and used to construct a recombinant plasmid for Cab: GFP .

The coding regions of the transit peptide of rubisco activase (RA) was PCR amplified from a λZAPII cDNA library using two specific primers (5'- TCTAGAATGGCCGCCGCAGTTTCC (SEQ ID NO: 7) and 5'- GGATCCATCTGTCTCCATCGGTTTG (SEQ ID NO: 8)) and ligated to the 5' end of the coding regions of GFP and RFP to construct recombinant plasmids for RA:GFP and RA:RFP, respectively.

The coding region of the Arabidopsis outer envelope membrane protein, AtOEP7, a homolog of OEP14 of pea was PCR amplified from a Arabidopsis genomic DNA using two specific primers (OEP7-F: 5'-GACGACGACGCAGCGATG (SEQ ID NO: 9) and OEP7-R: 5'-GGATCCCCAAACCCTCTTTGGATGT (SEQ ID NO: 10)) which were designed to remove the natural termination codon, and subsequently ligated to the 5' end of the coding regions of GFP and RFP to construct recombinant plasmids for AtOEP7:GFP and AtOEP:RFP, respectively. A recombinant plasmid for the nuclear localization signal (NLS), NLS:GFP, was constructed as described previously (Pih et al., 2000). A recombinant plasmid for NLS:RFP was constructed by replacing the GFP coding region with the RFP coding region in the recombinant gene for NLS:GFP.

A recombinant plasmid for the reporter protein GFP: SKL, which includes the proxisome targeting motif SKL (serine, lysine, leucine), was constructed by PCR amplification of 326GFP (Davis and Niestra, 1998) using two specific primers (5'- CCGTATGTTACATCACC (SEQ ID NO: 11) and 5'-

TTATAGCTTTGATTTGTATAGTTCATCCAT (SEQ ID NO: 12)).

Schematic diagrams of the reporter proteins constructed by the methods described above are presented in Figure 1.

Example 2. Preparation of protoplasts and transformation of protoplasts with recombinant plasmids.

(a) Preparation of protoplasts. Leaf tissues (5g) of 3-4 week-old Arabidopsis plants grown on soil in a green house were cut into small squares (5-10 mm²) with a new razor blade and incubated with 50 ml of the enzyme solution (0.25% Macerozyme R-10, 1.0% Cellulase R-10, 400 mM mannitol, 8 mM CaCl₂, 5 mM Mes-KOH, pH 5.6) at 22°C with gentle agitation (50-75rpm). After incubation, the protoplast suspension was filtered through a 100 μm mesh and protoplasts were collected by centrifugation at 46xg for 5 min. The pelleted protoplasts were resuspended in 5 to 10 ml of the W5 solution (154 mM NaCl, 125 mM CaCl₂, 5 mM KCI, 5 mM glucose, 1.5 mM Mes-KOH, pH 5.6), overlaid on top of 20 ml of 21% sucrose, and centrifuged for 10 min. at 78xg. The intact protoplasts at the interface were transferred to a new tube containing 20 ml of the W5 solution. The protoplasts were pelleted again by centrifugation at 55xg for 5 min and resuspended in 20 ml of the W5 solution. The protoplasts were incubated on ice for 30 minutes.

(b) Isolation of recombinant plasmid DNAs and transformation of protoplasts.

Recombinant plasmids were purified using Qiagen columns (Valencia, CA) according to the manufacture's protocol. To transform the protoplasts with the DNA, the protoplasts were pelleted again by centrifuge at 46xg for 5 min and resuspended in the

MaMg solution (400 mM Mannitol, 15 mM MgCl₂, 5 mM Mes-KOH, pH 5.6) at a density of

5xl0⁶ protoplasts/ml. The recombinant plasmids were introduced into Arabidodsis protoplasts by PEG-mediated transformation (Kim et al., 2001; Jin et al., 2001). Plasmid DNA (about 20-50 μg at a concentration of 2 μg/μl) was added to 300 μl of the protoplast suspension, and subsequently 325 μl of the PEG solution (400 mM Mannitol, 100 mM

Ca(N0₃)₂, 40% PEG 4000) was added. The mixture was gently mixed and incubated for 30 min at room temperature. After incubation, the mixture was diluted with 10 ml of the W5 solution. Protoplasts were recovered by centrifugation at 50xg for 5 min and resuspended in 3 ml of the W5 solution and incubated at 22°C in the dark.

Example 3. Expression of Group I reporter proteins and observation of their expression and localization.

The recombinant plasmids constructed in Example 1 were used to transform the protoplasts according to the method described in Example 2. The expression of the reporter proteins after the transformation was monitored as a function of time by capturing images using a fluorescence microscope (Axioplan fluorescence microscope, Zeiss, Germany) equipped with a cooled charge-coupled device (CCD) camera. The filter sets used were XF116 (exciter: 474AF20, dichroic: 500DRLP, emitter: 510AF23), XF33/E (exciter: 535DF35, dichroic: 570DRLP; emitter, 605DF50), and XF137 (exciter, 540AF30; dichroic, 570DRLP, emitter: 585ALP) (Omega, Inc, Brattleboro, VT) for GFP, RFP, and auto- fluorescence of chlorophyll, respectively. Data were then processed using Adobe (Mountain View, CA) Photoshop software, and the images were rendered in pseudo-color.

(a) Localization of the chloroplast targeting reporter proteins.

The green fluorescence of the reporter protein AtOEP7:GFP was observed at the outer envelop membrane of the chloroplast. The red fluorescence in Figure 2a is the auto- fluorescence of chloroplasts. Figure 2b shows the image obtained by eliminating this auto- fluorescence by using a filter. This result indicates that the fusion protein comprising the signal protein with the chloroplast envelope targeting signal and the fluorescent protein label was correctly targeted to the chloroplast envelope membrane.

Localization of the green fluorescence of the fusion proteins, RbcS: GFP, Cab: GFP, and RA:GFP are presented in Figure 2(c), 2(d), and 2(e), respectively. As shown in the figures, RbcS:GFP was targeted to the stroma of chloroplast, and Cab:GFP and RA:GFP also emitted the fluorescence in the chloroplast. These results indicate that the fusion proteins comprising the trafficking signal of RbcS, Cab, or RA and fluorescent reporter protein were targeted to the chloroplast.

(b) Mitochondria targeting of Fl-H⁺-ATPase:RFP. The red fluorescence of the reporter protein Fl-H⁺-ATPase:RFP was observed in the mitochondria (Figure 2(f)). This result indicates the fusion protein comprising the signal protein with the mitochondria targeting signal and the fluorescent protein was transported into the mitochondria.

(c) Peroxisome targeting of GFP:SKL. By analyzing the location of the green fluorescence from the reporter protein

GFP:SKL, it was observed that the green fluorescence of GFP:SKL was transported to the peroxisome as shown in Figure 2(g). This result indicates that the reporter protein comprising the peroxisome targeting signal, SKL (serine, lysine, leucine), and the fluorescent protein label was translocated to the peroxisome.

(d) Nuclear targeting of NLS:GFP.

By analyzing the location of the green fluorescence from the reporter protein, it was observed that the green fluorescence of NLS:GFP was transported to the nucleus as shown in Figure 2(h). This result indicates that the reporter protein comprising the nuclear localization signal and the fluorescent protein label was translocated to the nucleus.

Example 4. Confirmation of the chloroplast envelope targeting of AtOEP7:GFP by Western blot analysis. The recombinant plasmid for AtOEP7:GFP was constructed according to the method in Example 1. This recombinant plasmid was used to transform protoplasts according to the method in Example 2, and the transformed protoplasts were incubated for 24 hrs at 22°C. The total protein extract was prepared as follows. Five ml of cell lysate was centrifuged, suspended in 5 ml of the extraction solution (10 mM EDTA, 50 mM HEPES-KOH, 0.33 M sorbitol, 0.5 g/l BSA, 5 mM sodium ascorbate) at 4°C, and homogenized every three seconds for 20 min. The total protein extract was fractionated by ultra-centrifugation at 100,000xg to separate the soluble and membrane fractions. Both fractions were then electrophoresed on a 7.5% SDS/PAGE gel and transferred onto the PVDF membrane. The blot was probed with a polyclonal anti-GFP antibody. As presented in Figure 3, the result shows that the expressed signal protein was transported to the chloroplast envelope membrane and not present in the cytosol. This result indicates that localization of proteins, which is conventionally determined by Western blot analysis, can be identified by the method provided by the present invention.

Example 5. Construction of recombinant plasmids for expression of Group II proteins that are transported to subcellular organelles by endosomal trafficking.

The full length coding sequence of H⁺-ATPase (Arabidopsis AHA2) was amplified with two specific primers (5'-GAGATGTCGAGTCTCGAA (SEQ ID NO: 13) and 5'- CTCGAGCACAGTGTAGTGACTGG (SEQ ID NO: 14)) and ligated to the 5' end of the GFP coding sequence. The ligated recombinant gene was subcloned into the pUC vector under the control of the 35S promoter to construct a recombinant plasmid for H⁺- ATPase:GFP. The same procedure was applied in the following examples.

The coding sequence of the chaperone binding protein (BiP) (access number D82817) was amplified from an Arabidodsis cDNA library using two specific primers, BIP5 (5'-TACGCAAAAGTTTCCGAT-3' (SEQ ID NO: 15)) and BIP3 (5'- CTAGAGCTCATCGTGAGA-3' (SEQ ID NO: 16)). The amino terminal region (44 amino acids) and the carboxyl terminal region (80 amino acids) of this gene were ligated to the amino terminus and the carboxyl terminus of GFP or RFP, respectively, to construct recombinant plasmids for BiP:GFP and BiP:RFP. The sialtransferase (ST) cDNA was amplified from a λZAPII cDNA library using two specific primers (5'-ATGATTCATACCAACTTGAAG (SEQ ID NO: 17) and 5'- GGATCCACAACGAATGTTCCGGAA (SEQ ID NO: 18)). GFP or RFP was ligated in- frame to the carboxyl terminus of ST to construct ST: GFP or ST:RFP.

To construct a recombinant plasmid for the fusion protein Chi-n:RFP:Chi-c, a DNA fragment including the RFP coding sequence without the termination codon was inserted into the Sma I and Eco RN sites of the chitinase cDΝA of pea (access number M13968).

To express clone 500 encoding the vacuolar sorting receptor protein (BP-80) without the cytoplasmic tail, a recombinant plasmid for 500: GFP was constructed by inserting the GFP coding region without the termination codon into the EcoRI site of clone 500 (Kim et al., 2001).

For clone 526 encoding BP-80 with its cytoplasmic tail substituted by the tonoplast intrinsic protein (TIP), a recombinant plasmid for 526: GFP was constructed by inserting the coding region of GFP into the EcoRI site of clone 526.

To express the reporter protein for clone 491 encoding the BP-80 protein, recombinant plasmids for 491:GFP and 491:RFP were constructed by inserting clone 491 into the 5' end of the coding regions of GFP and RFP without the termination codon, respectively.

A recombinant plasmid for 500:GFP:KKXX was generated as follows: The GFP coding region without the termination codon was inserted into the EcoRI site of clone 500 (Jiang and Rogers, 1998) and KKXX was then added to the C-terminus of 500:GFP by PCR amplification using two specific primers (5'-GGATCCTCTAGAGGATCGATCCGG (SΕQ ID NO: 19) and 5'-

TTAGATGAGTTTCTTTTTCTCAAAGAAAGTTTTCAAAAGGAATCCCCCTCC (SΕQ ID NO: 20)). To express AtVTIla, a homolog of Arabidopsis t-SNARΕ which is transported from the tr πs-Golgi network to the storage prevacuole (Zheng et al., 1999), a recombinant plasmid for RFP:AtNTTla was constructed by ligating the coding region of AtNTIla to the C-terminus of the RFP coding region. A recombinant plasmid for AtVTI GFP was constructed by ligating the coding region of GFP to the C-terminus of the coding region of AtNTIla.

To express sporamin, a recombinant plasmid for SPO:GFP was constructed by ligating GFP to the carboxyl terminus of the sporamin B gene. Schematic diagrams of the reporter proteins expressed from the recombinant plasmids constructed as above are shown in Figure 4.

Example 6. Observation of the expression and localization of Group II reporter proteins.

Recombinant plasmids for H⁺-ATPase:GFP, ST:GFP, BiP:GFP, 526:GFP, Chi- n:RFP:Chi-c, and 500:GFP:KKXX were constructed as described in Example 5 and used to transform the protoplasts by the method of Example 2. Expression of the reporter proteins was monitored as a function of time using a fluorescence microscope as explained in Example 3. A part of the results is given in the following.

Fluorescence of the reporter protein H⁺-ATPase:GFP was observed in the plasma membrane (Figure 5(a)). Fluorescence of ST:GFP was observed in the Golgi apparatus (Figure 5(b)). The red fluorescence in these images is the auto-fluorescence of chloroplasts. Reporter proteins, BiP:RFP and 500:GFP:KKXX showed fluorescence in the lumen and the membrane of the endoplasmic reticulum, respectively (Figure 5(c) and 5(d)). 526:GFP showed fluorescence on the membrane of the storage vacuole (Figure 5(e)) and Chi- n:RFP:Chi-c showed fluorescence in the storage vacuole (Figure 5(f)). When chitinase was used as a signal protein, Chi-n:RFP, in which the carboxyl region of chitinase was not ligated, was not targeted to the storage vacuole, but it was present as speckles in the endoplasmic reticulum (Figure 5(g)). Fluorescence of SPO:GFP was distributed uniformly throughout the lytic vacuole (Figure 5(h)).

Example 7. Construction of recombinant plasmids to express Group III proteins that are specific to phospholipids. To construct the recombinant DNA for GFP:EBD, the C-terminal coding region (amino acid residue 1257 to 1411) of human early endosome antigen 1 (EEA1) was PCR amplified with two primers 5'-GAATTCGTGGCAATCTAGTCAACGG-3' (SEQ ID NO: 21) and 5'-CTAATGTTAGTGTAATATTAC-3' (SEQ ID NO: 22), and ligated to the C- terminus of the GFP coding sequence without the termination codon. This recombinant DNA was inserted to a pUC vector under the control of the 35S promoter to construct a recombinant plasmid. The same cloning procedure was applied in the examples hereafter.

A recombinant plasmid for a EBD derivative, GFP.EBDC1358S, was prepared using a primer directing replacement of the amino acid residue 1358 to serine.

A recombinant plasmid for the fusion protein of Arabidopsis Pleckstrin homology (PH) domain, GFPAtPH, was constructed by PCR amplification using two primers 5'- CCCGGGAAATGGAGAGTATGTGGCGA-3' (SEQ ID NO: 23) and 5'- TAATCACCGCCTGTGATCATA-3' (SEQ ID NO: 24). A recombinant plasmid for the fusion protein of FAPP including the PH domain, GFP:FAPP, was constructed by PCR amplification using two primers 5'-CTCGAGATGGAGGGGGTTCTGTACAAG-3' (SEQ ID NO: 25) and 5'-TCACGCTTTGGAGCTCCCAAGGGC-3' (SEQ ID NO: 26). A recombinant plasmid for PH:GFP was constructed by the method of Kost B et al. (1998).

Schematic diagrams of the reporter proteins constructed as above are shown in Figure 6.

Example 8. Observation of the expression and localization of Group III reporter proteins.

Recombinant plasmids for GFP:EBD, GFP:AtPH, GFP:FAPP, and GFP:PH, were constructed as described in Example 7 and used to transform the protoplasts by the method of Example 2. Expression of the reporter proteins was monitored as a function of time using a fluorescence microscope as explained in Example 3. A part of the results is given in the following.

The reporter proteins, GFP:EBD and GFP:AtPH, showed fluorescence at the outer membrane of vacuole, indicating the presence of phosphatidylinositol 3-phosphate (PI(3)P) in the outer membrane of vacuole. GFP:FAPP and GFP:PH showed fluorescence at the plasma membrane indicating the presence of phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 4,5-diphosphate (PI(4,5)P2), respectively, in the plasma membrane. These results show that it is possible to use the phospholipid-specific protein or its portion as a signal protein to target a protein to the phospholipid-containing cellular compartments (see Figure 7).

Example 9. The effect of wortmannin on the intracellular trafficking of RbcS: GFP.

(a) Plasmid construction, transformation, and expression of the fusion protein.

A recombinant plasmid for RbcS: GFP was constructed as described in Example 1.

Isolation of the recombinant plasmid, preparation of protoplasts, and transformation of protoplasts were performed as in Example 2. The protoplast suspension was treated with wortmannin at a concentration of 5 μg/ml. Then the protoplasts were transformed and incubated in the dark. Expression of the fusion protein was observed as in Example 3.

(b) The effect of wortmannin on the intracellular trafficking of the fusion protein. The effect of wortmannin on the trafficking of RbcS: GFP was examined.

Wortmannin is known as a specific inhibitor of phosphatidyl 3-phosphate (PI(3)P) and phosphatidylinositol 4-phosphate (PI(4)P) (Ui et al., 1995). Localization of the green fluorescence in the wortmannin-treated protoplast was compared with that of the control protoplast that was not treated with wortmannin. As shown in Figure 8, in contrast to the control protoplast in which the green fluorescence of RbcS: GFP was targeted to the chloroplast as expected (Figure 8(a)), the green fluorescence was not translocated to the chloroplast in the presence of wortmannin, but observed as either speckles or aggregates (Figure 8(b) and 8(c)). This result indicates that wortmannin inhibits trafficking of the chloroplast-targeting protein from the cytosol to the chloroplast.

Example 10. The effect of bafilomycin Al (BafAl), known as an inhibitor of the vacuolar type H⁺-ATPase, on retrograde trafficking of 500:GFP:KKXX.

(a) Plasmid construction, transformation, and expression of the fusion protein.

The recombinant plasmid for 500:GFP:KKXX was constructed as described in Example 5. Isolation of the recombinant plasmid, preparation of protoplasts, and transformation of protoplasts were performed as in Example 2. The protoplast suspension was treated with bafilomycin Al at a concentration of 5 μg/ml. Then the protoplasts were transformed and incubated in the dark. Expression of the fusion protein was observed as in Example 3.

(b) The effect of bafilomycin Al (BafAl) on the trafficking of the fusion protein. Localization of the green fluorescence in the BafAl -treated protoplast was compared with that of the control protoplast that was not treated with BafAl. As shown in Figure 9, while the green fluorescence was observed as numerous networks in the control protoplast (Figure 9(a) and 9(b)), it was observed as a ring pattern on the plasma membrane (Figure 9c) and the vacuolar membranes (Figure 9d) in the presence of BafAl. This result indicates that BafAl inhibits the retrograde trafficking of 500:GFP:KKXX in the Arabidopsis protoplast and causes transport of the reporter protein to the plasma membrane or the vacuolar membrane. Example 11. The effect of a specific inhibitor on the localization of two reporter proteins.

(a) Plasmid construction, transformation, and expression of the fusion protein Recombinant plasmids for the reporter proteins, BiP:GFP and STRFP that are specific to the endoplasmic reticulum and the Golgi apparatus, respectively, were constructed as described in Example 5. Isolation of the recombinant plasmid, preparation of protoplasts, and transformation of protoplasts were performed as in Example 2. The protoplast suspension was treated with brefeldin A at a concentration of 5 μg/ml. Then the protoplasts were transformed and incubated in the dark. Expression of the fusion protein was observed as in Example 3.

(b) Distribution of fluorescence from the two reporter proteins.

Brefeldin A (BFA) is known as an inhibitor of ADP-ribosylation factors (Arfs) in the animal cell (Morinaga et al., 1999). In the control protoplast, the green fluorescence of BiP:GFP was observed in the endoplasmic reticulum (Figure 10(a)) and the red fluorescence of STRFP was observed in the Golgi apparatus (Figure 10(b)). When the protoplast was treated with BFA, ST:GFP was targeted to the endoplasmic reticulum instead of the Golgi apparatus that was destroyed by BFA (Figure 10(e)). As observed, the fluorescent images of the chemical-treated protoplasts are distinctively different from those of the control protoplasts (Figure 10(c) and 10(f)). This suggests that the intracellular trafficking of two or more proteins can be simultaneously detected by using two or more fluorescent proteins with different colors. The result observed for ST:GFP shows the destruction process of the Golgi apparatus.

Example 12. The effect of brefeldin A (BFA) on the biogenesis and structure conservation of the endoplasmic reticulum.

(a) Plasmid construction, transformation, and expression of the fusion protein.

A recombinant plasmid for BiP:RFP was constructed as described in Example 5.

Isolation of the recombinant plasmid, preparation of protoplasts, and transformation of protoplasts were performed as in Example 2. The protoplast suspension was treated with brefeldin A at a concentration of 5 μg/ml. Then the protoplasts were transformed and incubated in the dark. Expression of the fusion protein was observed as in Example 3.

(b) The effect of chemicals on the trafficking of the fusion protein. Localization of the red fluorescence in the BFA-treated protoplast was compared with that of the control protoplast that was not treated with BFA. As shown in Figure 11(a), while the red fluorescence of BiP:RFP was present along the structure of the endoplasmic reticulum in the control protoplast, the structure of the ER was observed to be destroyed (Figure 11(c)) when treated with BFA. Effect of using a reporter protein that specifically binds to a subcellular organelle can be clarified by comparing the fluorescence images with the images taken by an optical microscope under bright field (Figure 11(a) and 11(d)).

Examplel3. Inhibition of trafficking of proteins that are specific to phospholipids.

(a) Plasmid construction, transformation, and expression of the fusion protein. Recombinant plasmids for the reporter proteins, GFP:EBD and GFP:EBDC1358S were constructed as described in Example 7. These recombinant plasmids were used to transform the protoplasts according to the method of Example 2. The transformed protoplasts were treated with wortmannin at a concentration of 1.0 μg/ml or with 2-(4-morpholinyl)-8- phenyl-4H-l-benzopyran-4-on, a specific inhibitor of phosphatidylinositol 3-kinase, at a concentration of 10 μg/ml (LY294002, Nlahos et al., 1994) and incubated at 22°C. Fluorescence images were monitored at various time points.

(b) The effect of chemicals on the localization of the fusion proteins.

In the control protoplast that was not treated with the chemicals, the green fluorescence was localized in the endosome along the distribution of the EBD-binding phospholipid PI(3)P (Figure 12(a)). In the protoplasts treated with wortmannin or LY294002, however, the green fluorescence was distributed uniformly throughout the cytosol (Figure

12(a)). On the other hand, when the same experiment was performed for GFP:EBDC1358S in which the amino acid residue 1358 is mutates, the chemicals did not affect the distribution of the fluorescence.

Example 14. Change in the expression level induced by cycloheximide, an inhibitor of the protein expression.

(a) Plasmid construction, transformation, and expression of the fusion protein. A recombinant palsmid for RA:GFP was constructed as described in Example 1.

Isolation of the recombinant plasmid, preparation of protoplasts, and transformation of protoplasts were performed as in Example 2. The protoplast suspension was treated with cycloheximide a concentration of 5 μg/ml. Then the protoplasts were transformed and incubated at 22°C in the dark. Expression of the fusion protein was observed as in Example 3.

(b) The effect of the chemical on the expression of the fusion protein.

The intensity of the green fluorescence was decreased in the cycloheximide treated- protoplast (Figure 13(a)) compared to that in the control protoplast that was not treated with cycloheximide (Figure 13(b)). This result shows that the expression of the reporter protein is inhibited, suggesting that the effect of a chemical on the transcription and/or translation of protein can be visualized. The red fluorescence images in Figure 13(c) and 13(d) shows the auto-fluorescence of the chloroplast, which are measured to relatively compare the growth and metabolism of the cells.

The present invention described above is not limited by the aforementioned examples and the attached drawings. The present invention can be substituted, changed, and modified without departing from the technical thoughts described in the specification and the claims, and such substitutions, changes, and modifications fall within the spirit and scope of the present invention.

REFERENCES Patents:

Harpold, M. M., and Brust, P. US 5,401,629. ASSAY METHOD AND SOMPOSITIONS USEFUL FOR MEASURING THE TRANSDUCTION OF AN INTRACELLULAR SIGNAL.

Thastrup, O., Tullin, S., Poulsen, L. K., and Bjorn, S. P. W096/23898. A METHOD OF DETECTING BIOLOGICALLY ACTIVE SUBSTANCES

Ward, W., and Chalfie, M. W095/21191. BIOLUMINESCENT INDICATOR BASED UPON THE EXPRESSION OF A GENE FOR A MODIFIED GREEN- FLUORESCENT PROTEIN.

Chalfie, M. and Prasher, D. US 5,491,084. USES OF GREEN-FLUORESCENT PROTEIN

Evans, K. W098/21355. MUTANTS OF GREEN FLUORESCENT PROTEIN.

Publications: Davis, S. J., and Viestra, R. D. (1998). Soluble, highly fluorescent variants of green fluorescent protein (GFP) for use in higher plants. Plant Mol. Biol. 36, 521-528.

Dowler, S., Currie, R. A., Campbell, D. G., Deak, M., Kular, G., Downes, C. P., and Alessi, D. R. (2000). Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J. 351(Pt 1), 19-31.

Gillooly, D. J., Morrow, I. C, Lindsay, M., Gould, R., Bryant, N. J., Gaullier, J- M., Parton, R. G., and Stenmark, H. (2000). Localization of phosphatidylinositol 3- phosphate in yeast and mammalian cells. EMBO J. 19, 4577-4588.

Goldfarb, D. S., Gariepy, J., Schoolnik, G., and Konberg, R. D. (1986). Synthetic peptides as nuclear localization signals. Nature 322, 641-644.

Hu and Cheng (1995). Expression of aequorea green fluorescent protein in plant cells. FEBS Lett. 369, 331-334.

Jiang. L., and Rogers, J. C. (1998). Integral membrane protein sorting to vacuoles in plant cells: evidence for two pathways. J. Cell Biol. 143, 1183-1199. Jin, J. B., Kim, T. A., Kim, S. J., Lee, S. H., Kim, D. H., Cheong, G.-W., and

Hwang, I. (2001). A new Dynamin-like protein, ADL6, is involved in trafficking from the tr ns-Golgi network to the central vacuole in Arabidopsis. Plant Cell (in press)

Kaether and Gerdes (1995) Visualization of protein transport along the secretory pathway using green fluorescent protein. FEBS Lett. 369, 267-271. Kim, D. H., Eu, Y. J., Yoo, C. M., Kim, Y. W., Pih, K. T., Jin, J. B., Kim, S. J.,

Stenmark, H., and Hwang, I. (2001). Trafficking of Phosphatidylinositol 3-Phosphate from the trαns-Golgi Network to the Lumen of the Central Vacuole in Plant Cells. Plant Cell 13, 287-301.

Kost, B., Spielhofer, P., and Chua, N. H. (1998). A GFP-mouse talin fusion protein labels plant actin filaments in vivo and visualizes the actin cytoskeleton in growing pollen tubes. Plant J. 16, 393-401.

Morinaga, N., Adamik, R., Moss, J., and Vaughan, M. (1999). Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors. J. Biol. Chem. 274, 17417-17423. Morise et al. (1974). Intermolecular energy transfer in the bioluminescent system of aequorea. Biochem. 13, 2656-2662.

Niwa, Y., Hirano, T., Yoshimoto, K., Shimizu, M., and Kobayashi, H. (1999). Non-invasive quantitative detection and applications of non-toxic, S65T-type green fluorescent protein in living plants. Plant J. 18, 455-463 Pih, K. T., Yi, M. J., Liang, Y. S., Shin, B. J., Cho, M. J., Hwang, I., and Son, D.

(2000). Molecular clonging and targeting of a fibrillarin homolog from Arabidopsis. Plant Physiol. 123, 51-58.

Stauffer, T. P., Ahn, S. and Meyer, T. (1988). Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr. Biol. 8, 343-346. Ui, M., Okada, T., Hazeki, K., and Haxeki, O. (1995). Wormannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. TIBS 20, 303-307.

Vlahos, C, Matter, W. E, Jui, K., and Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyι)-8-phenyl-4H-l-benzopyran-4-one (LY294002). J. Biol. Chem.269, 5241-5248. Weiss, E. L., Bishop, A. C, Shokat, K. M., and Drubin, D. G. (2000). Chemical genetic analysis of the budding-yeast p21-activated kinase cla4p. Nat. Cell Biol. 2, 677-685.

Zheng, H., von Mollard, G. E, Kovaleva, V., Stevens, T. H., and Raikhel, N. V. (1999). The plant vesicle-associated SNARE AtNTIla likely mediates vesicle transport from the trans-Golgi network to the prevacuolar compartment. Mol. Biol. Cell 10, 2251-2264.

Claims

What is claimed is:

1. A method for detecting specific characteristics related to trafficking and localization of a selected protein in a cell, which method comprises: (a) preparing a recombinant gene comprising a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto;

(b) preparing a recombinant plasmid including the recombinant gene with a promoter and a terminator operably linked thereto so that the recombinant gene can be expressed in the cell;

(d) expressing the reporter protein comprising the signal protein and the fluorescent protein in the transformed cell; and

(e) detecting the cellular distribution of the reporter protein by monitoring the fluorescence image of the transformed cell during the expression or trafficking, or thereafter.

2. A method for screening chemicals that affect specific characteristics related to trafficking and localization of a selected protein in a cell, which method comprises: (a) preparing a recombinant gene comprising a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto;

(b) preparing a recombinant plasmid comprising the recombinant gene with a promoter and a terminator operably linked thereto so that the recombinant gene can be expressed in the cell (c) transforming the cell with at least one recombinant plasmid prepared in step (b),

(d) expressing the reporter protein comprising the signal protein and the fluorescent protein in the transformed cell, while treating the transformed cell with a chemical before, after, or at the same time as the expression; (e) detecting the cellular distribution of the reporter protein by monitoring the fluorescence image of the transformed cell treated with the chemical during the expression or trafficking, or thereafter; and

(f) determining the effect of the chemical by comparing the fluorescence image obtained in step (e) with that of a control transformed cell which is not treated with the chemical.

3. A method for detecting specific characteristics related to trafficking and localization of a selected protein in a plant cell, which method comprises:

(b) preparing a recombinant plasmid including the recombinant gene with a promoter and a terminator operably linked thereto so that the recombinant gene can be expressed in the cell; (c) transforming the protoplast of the plant cell whose cell wall is removed with at least one recombinant plasmid prepared in step (b);

4. A method for screening chemicals that affect specific characteristics related to trafficking and localization of a selected protein in a plant cell, which method comprises: (a) preparing a recombinant gene comprising a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto;

(c) transforming the protoplast of the plant cell whose cell wall is removed with at least one recombinant plasmid prepared in step (b);

5. The method according to any of claims 1 and 2, wherein the cell is a eukaryotic cell.

6. The method according to any of claims 1 to 4, wherein the fluorescent protein is. one selected from the group consisting of green fluorescent protein (GFP), red fluorescent protein (RFP), mutants thereof, and derivatives thereof.

7. The method according to any of claims 1 to 4, wherein the specific subcellular organelle targeted by the reporter protein is one selected from the group consisting of nucleus, mitochondria, chloroplast, and peroxisome.

8. The method according to any of claims 1 to 4, wherein the coding region of the signal protein included in the recombinant gene is a coding sequence of a full length protein selected from the group consisting of NLS (nuclear localization signal), AtOEP7, Cab (chlorophyll a/b binding protein), SKL (peroxisome targeting motif), RbcS (Rubisco Small Subunit), RA (Rubisco Activase), and Fl-H⁺-ATPase, or a portion thereof that includes the trafficking signal.

9. The method according to any of claims 1 to 4, wherein the specific subcellular organelle targeted by the reporter protein is one selected from the group consisting of plasma membrane, endoplasmic reticulum, Golgi apparatus, ribosome, lysosome, cytoskeleton, centriole, storage vacuole, lytic vacuole, and prevacuolar compartment.

10. The method according to any of claims 1 to 4, wherein the coding region of the signal protein included in the recombinant gene is a coding sequence of a full length protein selected from the group consisting of H⁺-ATPase, BiP (chaperon binding protein), ST (sialytransferase), Chi (chitinase), clone 526, clone 491, clone 500, AtVTIla, and SPO (sporamin), or a portion thereof that includes the trafficking signal.

11. The method according to any of claims 1 to 4, wherein the coding region of the signal protein included in the recombinant gene encodes a protein that binds specifically to a phospholipid.

12. The method according to any of claims 1 to 4, wherein the coding region of the signal protein included in the recombinant gene is a coding sequence of a full length protein selected from the group consisting of EBD, AtPH, FAPPl, and PH which bind specifically to phospholipids, or a portion thereof that includes the trafficking signal.

13. The method according to any of claims 2 and 4, wherein the chemical is one selected from the group consisting of chemical compounds, polypeptides, mixtures of chemical compounds and polypeptides, and extracts of natural products.

14. The method according to any of claims 1 to 4, wherein the fluorescence image is monitored at one or more fluorescence wavelengths using a fluorescence microscope equipped with optical filters, each of which transmit fluorescence at a specific wavelength.

15. The method according to any of claims 2 and 4, wherein the chemical inhibits or enhances the trafficking of the reporter protein, so that the trafficking speed or the distribution of the reporter protein in the transformed cell treated with the chemical is altered compared to those in the control transformed cell.

16. The method according to any of claims 2 and 4, wherein the chemical inhibits or enhances the transcription in which mRNA is produced from the recombinant plasmid or the translation in which the reporter gene is produced from mRNA, so that the intensity and the distribution of the reporter protein in the transformed cell treated with the chemical is altered compared to those in the control transformed cell.

17. The method according to claims 2 and 4, wherein the chemical causes the cytotoxicity such as deformation, damage, or disruption of the cell or the subcellular organelles, so that the intensity and the distribution of the reporter protein in the transformed cell treated with the chemical is altered compared to those in the control transformed cell.

18. The method according to any of claims 1 to 4, wherein the method of introducing the recombinant plasmid into the cell is one selected from the group consisting of the methods of using a chemical such as PEG (polyethylene glycol), calcium phosphate, and DEAE-dextran, lifofection using cationic lipid, microinjection, electroporation, and electrofusion.

19. The method according to any of claims 1 to 4, wherein introduction of the recombinant plasmid into the cell is conducted by using 5 to 40% PEG.

20. The method according to any of claims 1 to 4, wherein observation of the expression, the trafficking, or the localization of the reporter protein is conducted in the time range of 5 min to 80 hrs during or after the incubation of the transformed cell.

21. A recombinant gene comprising a gene encoding a signal protein which includes a trafficking signal targeting to a specific subcellular organelle and a gene encoding a fluorescent protein linked thereto.

22. The recombinant gene according to claim 21, wherein the coding region of the signal protein is a coding sequence of a full length protein selected from the group consisting of AtOEP7 (Arabidopsis outer membrane envelope), RbcS (Rubisco small subunit), RA (Rubisco activase), Cab (Chlorophyll a/b binding protein), H⁺-ATPase, BiP (Chaperon binding protein), Chi (Chitinase), clone 526, clone 491, clone 500, AtNTIla, SPO (sporamin), AtPH, and FAPPl, or a portion thereof that includes the trafficking signal.

23. The recombinant gene according to claim 21, wherein the specific subcellular organelle targeted by the reporter gene expressed from the recombinant gene is one selected from the group consisting of chloroplast, plasma membrane, endoplasmic reticulum, Golgi apparatus, storage vacuole, lytic vacuole, and prevacuolar compartment.

24. The recombinant gene according to claim 21, wherein the fluorescent protein is one selected from the group consisting of green fluorescent protein (GFP), red fluorescent protein (RFP), mutants thereof, and derivatives thereof.

25. A recombinant plasmid comprising the recombinant gene of any of claims 21 to 24 with a promoter and a terminator operably linked thereto so that the recombinant gene can be expressed in a cell.

26. A fusion protein expressed from the recombinant gene of any of claims 21 to 24.

27. A method of using the fusion protein of claim 26 as a carrier for targeting chemicals to a subcellular organelle.

28. The recombinant plasmid of claim 25, wherein the promoter is 35 S promoter.